Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Northrop Grumman Corporation (NOC) Price & Performance

BioNTech SE - ADRTrade
Northrop Grumman CorporationTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Northrop Grumman Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Northrop Grumman Corporation trades at $575.54 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 3.5× BioNTech SE - ADR's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXNOC
Market Cap
$23.31B$81.78B
Sector
HealthIndustrials
52-Week High
$119.34$768.02
52-Week Low
$83.89$496.02
Enterprise Value
$6.60B$95.77B
Dividend Yield
1.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC